Xuananh Pham Tran, MD
Obstetrics/Gynecology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Offices
- 2
Offices
2 locations · UCSF Health Medical Foundation · 40 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$22,259
Medicare paid this office $22,259 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 49 | $6,366 | $79 |
| Return visit (30+ min) | 27 | $3,389 | $113 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 17 | $2,277 | $127 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,483 | $48 |
| New patient visit (30+ min) | 19 | $1,275 | $67 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 73 · Women 100% · Also on Medicaid 32% · Health risk score 0.81. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 72% · Diabetes 28% · Cancer 19% · Coronary heart disease 17% · Depression 16% · Chronic kidney disease 13% · Atrial fibrillation 13%.
The office billed $67,975, Medicare allowed $30,782 and paid $22,259; for 239 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 239 | 73 | 0.81 | $67,975 | $22,259 |
| 2023 | 187 | 467 | 69 | 1.03 | $98,170 | $39,761 |
| 2022 | 168 | 405 | 71 | 1.16 | $94,287 | $42,567 |
| 2021 | 156 | 348 | 68 | 0.87 | $79,442 | $34,224 |
| 2020 | 81 | 156 | 69 | 0.85 | $34,368 | $14,459 |
| 2019 | 120 | 229 | 70 | 0.84 | $50,783 | $21,331 |
| 2018 | 168 | 307 | 67 | 0.94 | $54,988 | $22,870 |
| 2017 | 186 | 375 | 66 | 1.12 | $69,161 | $29,820 |
| 2016 | 119 | 246 | 66 | 1.18 | $62,587 | $24,826 |
| 2015 | 128 | 286 | 67 | 1.05 | $64,757 | $28,021 |
| 2014 | 121 | 253 | 67 | 0.98 | $42,773 | $18,891 |
| 2013 | 66 | 160 | 73 | 0.98 | $27,437 | $11,471 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Short return visit (20+ min) | 78 | $12,192 | $80 |
| Return visit (30+ min) | 32 | $4,434 | $114 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 77 | $3,643 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 54 | $2,969 | $55 |
| New patient visit (30+ min) | 28 | $2,860 | $102 |
| New patient visit (45+ min) | 17 | $2,234 | $131 |
| Biopsy of lining of uterus | 11 | $1,080 | $98 |
2022: 7 services
| Return visit (30+ min) | 52 | $7,564 | $105 |
| Short return visit (20+ min) | 61 | $7,461 | $74 |
| New patient visit (45+ min) | 25 | $3,417 | $137 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 59 | $2,784 | $47 |
| New patient visit (30+ min) | 30 | $2,441 | $81 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,665 | $54 |
| Biopsy of lining of uterus | 12 | $1,102 | $92 |
2021: 8 services
| Short return visit (20+ min) | 66 | $7,969 | $79 |
| Return visit (30+ min) | 39 | $4,965 | $110 |
| New patient visit (30+ min) | 40 | $3,639 | $91 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 47 | $2,256 | $48 |
| Biopsy of lining of uterus | 15 | $1,601 | $100 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 29 | $1,590 | $55 |
| New patient visit (45+ min) | 11 | $1,580 | $144 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $1,457 | $132 |
2020: 4 services
| Short return visit (20+ min) | 32 | $2,755 | $67 |
| Return visit (30+ min) | 20 | $2,397 | $92 |
| New patient visit (30+ min) | 22 | $1,912 | $87 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,201 | $48 |
2019: 5 services
| Short return visit (20+ min) | 44 | $3,748 | $60 |
| Return visit (30+ min) | 21 | $2,516 | $93 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 45 | $2,092 | $46 |
| New patient visit (30+ min) | 22 | $1,758 | $80 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $748 | $53 |
2018: 7 services
| Short return visit (20+ min) | 66 | $5,226 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 71 | $3,031 | $43 |
| New patient visit (30+ min) | 28 | $2,263 | $81 |
| Return visit (30+ min) | 25 | $2,164 | $80 |
| Biopsy of lining of uterus | 11 | $1,052 | $88 |
| Complete ultrasound scan of pelvis | 11 | $870 | $79 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 13 | $666 | $51 |
2017: 6 services
| Short return visit (20+ min) | 72 | $5,971 | $60 |
| Return visit (30+ min) | 35 | $3,186 | $86 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 71 | $3,099 | $44 |
| New patient visit (30+ min) | 36 | $2,921 | $81 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 30 | $1,571 | $52 |
| Biopsy of lining of uterus | 17 | $1,360 | $80 |
2016: 4 services
| Short return visit (20+ min) | 33 | $3,450 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 54 | $2,299 | $43 |
| Return visit (30+ min) | 20 | $1,807 | $79 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,592 | $51 |
2015: 7 services
| Short return visit (20+ min) | 46 | $3,999 | $60 |
| Return visit (30+ min) | 30 | $3,409 | $87 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 48 | $2,087 | $43 |
| New patient visit (45+ min) | 12 | $1,653 | $138 |
| New patient visit (30+ min) | 18 | $1,098 | $61 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 20 | $1,035 | $52 |
| Short return visit | 13 | $636 | $37 |
2014: 7 services
| Short return visit (20+ min) | 35 | $3,962 | $63 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 51 | $2,241 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 37 | $1,959 | $53 |
| New patient visit (45+ min) | 13 | $1,790 | $138 |
| Return visit (30+ min) | 13 | $1,180 | $91 |
| New patient visit (30+ min) | 13 | $1,060 | $82 |
| Short return visit | 13 | $494 | $35 |
2013: 3 services
| Short return visit (20+ min) | 27 | $3,127 | $60 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 33 | $1,862 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 34 | $1,544 | $45 |
Medicaid work
$2,548 in 2024
Medicaid paid $2,548 for 295 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 152 | $2,285 |
| Return visit (30+ min) | 61 | $263 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 82 | $0 |
| 2024 | 295 | 3 | 21 | $2,548 |
| 2023 | 2,505 | 7 | 57 | $53,324 |
| 2022 | 2,632 | 7 | 67 | $41,286 |
| 2021 | 1,998 | 8 | 52 | $35,319 |
| 2020 | 532 | 8 | 37 | $8,641 |
| 2019 | 1,312 | 8 | 32 | $23,447 |
| 2018 | 1,782 | 11 | 39 | $84,941 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 174 | $15,478 |
| Return visit (30+ min) | 374 | $15,227 |
| Short return visit (20+ min) | 397 | $11,385 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 367 | $6,985 |
| Service | 42 | $2,297 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,013 | $1,136 |
| URINE PREGNANCY TEST | 138 | $815 |
2022
| New patient visit (30+ min) | 210 | $12,638 |
| Return visit (30+ min) | 437 | $12,330 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 370 | $8,256 |
| Short return visit (20+ min) | 299 | $6,230 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 1,168 | $1,289 |
| FETAL NON-STRESS TEST | 38 | $287 |
| URINE PREGNANCY TEST | 110 | $256 |
2021
| New patient visit (30+ min) | 301 | $11,973 |
| Return visit (30+ min) | 443 | $9,810 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 72 | $6,532 |
| Short return visit (20+ min) | 300 | $4,975 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 780 | $952 |
| New patient visit (45+ min) | 12 | $723 |
| URINE PREGNANCY TEST | 76 | $238 |
| FETAL NON-STRESS TEST | 14 | $116 |
2020
| Return visit (30+ min) | 105 | $2,744 |
| Short return visit (20+ min) | 99 | $1,923 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 18 | $1,633 |
| New patient visit (45+ min) | 13 | $883 |
| FETAL NON-STRESS TEST | 100 | $742 |
| New patient visit (30+ min) | 12 | $538 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 158 | $107 |
| URINE PREGNANCY TEST | 27 | $71 |
2019
| ANTEPARTUM CARE ONLY 4-6 VISITS | 113 | $8,255 |
| Return visit (30+ min) | 218 | $6,606 |
| Short return visit (20+ min) | 219 | $3,400 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 25 | $2,276 |
| FETAL NON-STRESS TEST | 164 | $1,410 |
| New patient visit (30+ min) | 77 | $1,063 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 482 | $396 |
| URINE PREGNANCY TEST | 14 | $42 |
2018
| OBSTETRICAL CARE | 56 | $31,514 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 153 | $13,685 |
| Return visit (30+ min) | 308 | $12,276 |
| Short return visit (20+ min) | 270 | $8,008 |
| New patient visit (30+ min) | 94 | $4,945 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 115 | $4,884 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 104 | $4,416 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation plus detailed fetal anatomic examination, transabdominal approach; single or first gestation | 20 | $2,212 |
| FETAL NON-STRESS TEST | 252 | $2,190 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 383 | $724 |
| URINE PREGNANCY TEST | 27 | $87 |
Drugs they prescribed that Part D paid
$23,617
Pharmacies billed $23,617 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 132) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
85 generic and 47 brand-name prescriptions · $23,617 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Premarin | 30 | $12,857 | $429 |
| Estradiol | 22 | $914 | $42 |
Year by year
| 2024 | 132 | 60 | 0% (0) | 36% | $23,617 |
| 2023 | 190 | 86 | None | 29% | $28,089 |
| 2022 | 241 | 101 | 5% (11) | 27% | $31,416 |
| 2021 | 220 | 94 | 6% (13) | 27% | $23,658 |
| 2020 | 242 | 65 | None | 14% | $15,944 |
| 2019 | 324 | 81 | None | 22% | $32,683 |
| 2018 | 386 | 103 | 3% (11) | 27% | $43,022 |
| 2017 | 307 | 81 | 4% (12) | 26% | $29,005 |
| 2016 | 366 | 71 | 5% (18) | 27% | $30,042 |
| 2015 | 345 | 76 | None | None | $29,232 |
| 2014 | 350 | 66 | None | 33% | $25,895 |
| 2013 | 321 | 56 | 4% (12) | 38% | $29,660 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Premarin | 33 | $14,688 | $445 |
| Estradiol | 34 | $3,780 | $111 |
2022: 4 drugs
| Premarin | 42 | $17,453 | $416 |
| Estradiol | 33 | $4,897 | $148 |
| Ibuprofen | 12 | $89 | $7 |
| Fluconazole | 12 | $61 | $5 |
2021: 6 drugs
| Premarin | 41 | $14,786 | $361 |
| Estradiol | 25 | $3,533 | $141 |
| Raloxifene | 15 | $1,259 | $84 |
| Hydrocodone-Acetaminophen | 12 | $85 | $7 |
| Ibuprofen | 17 | $70 | $4 |
| Misoprostol | 16 | $23 | $1 |
2020: 4 drugs
| Premarin | 21 | $7,600 | $362 |
| Raloxifene | 21 | $2,019 | $96 |
| Dotti | 11 | $344 | $31 |
| Ibuprofen | 14 | $52 | $4 |
2019: 6 drugs
| Premarin | 36 | $13,471 | $374 |
| Raloxifene | 18 | $2,415 | $134 |
| Estradiol | 25 | $2,334 | $93 |
| Atorvastatin | 16 | $224 | $14 |
| Simvastatin | 11 | $94 | $9 |
| Ibuprofen | 12 | $41 | $3 |
2018: 11 drugs
| Premarin | 42 | $16,341 | $389 |
| Raloxifene | 21 | $3,881 | $185 |
| Prempro | 12 | $2,755 | $230 |
| Vivelle-Dot | 11 | $2,166 | $197 |
| Estradiol | 20 | $1,004 | $50 |
| Medroxyprogesterone Acetate | 11 | $517 | $47 |
| Metoprolol | 11 | $377 | $34 |
| Gabapentin | 13 | $266 | $20 |
| Triamcinolone Acetonide | 16 | $169 | $11 |
| Fluconazole | 18 | $108 | $6 |
| Simvastatin | 14 | $92 | $7 |
2017: 8 drugs
| Premarin | 22 | $8,283 | $376 |
| Estrace | 17 | $4,973 | $293 |
| Raloxifene | 19 | $3,442 | $181 |
| Vivelle-Dot | 13 | $2,588 | $199 |
| Prempro | 13 | $2,340 | $180 |
| Medroxyprogesterone Acetate | 14 | $741 | $53 |
| Estradiol | 17 | $696 | $41 |
| Simvastatin | 14 | $101 | $7 |
2016: 11 drugs
| Premarin | 33 | $10,187 | $309 |
| Raloxifene | 24 | $4,056 | $169 |
| Estrace | 14 | $3,737 | $267 |
| Prempro | 12 | $1,901 | $158 |
| Lopreeza | 11 | $1,089 | $99 |
| Estradiol | 19 | $668 | $35 |
| Medroxyprogesterone Acetate | 15 | $602 | $40 |
| Metoprolol | 16 | $363 | $23 |
| Atorvastatin | 18 | $201 | $11 |
| Simvastatin | 16 | $119 | $7 |
| Ibuprofen | 13 | $70 | $5 |
2015: 12 drugs
| Premarin | 34 | $9,580 | $282 |
| Raloxifene | 14 | $2,642 | $189 |
| Prempro | 13 | $1,728 | $133 |
| Estradiol | 24 | $681 | $28 |
| Medroxyprogesterone Acetate | 23 | $639 | $28 |
| Metronidazole | 12 | $477 | $40 |
| Clotrimazole-Betamethasone | 11 | $443 | $40 |
| Famciclovir | 12 | $392 | $33 |
| Metoprolol | 14 | $222 | $16 |
| Glimepiride | 11 | $145 | $13 |
| Simvastatin | 22 | $94 | $4 |
| Amlodipine Besylate | 11 | $36 | $3 |
2014: 10 drugs
| Evista | 13 | $6,083 | $468 |
| Premarin | 21 | $4,710 | $224 |
| Prempro | 14 | $1,590 | $114 |
| Medroxyprogesterone Acetate | 22 | $519 | $24 |
| Metoprolol | 16 | $361 | $23 |
| Estradiol | 21 | $228 | $11 |
| Metronidazole | 12 | $199 | $17 |
| Simvastatin | 24 | $160 | $7 |
| Zolpidem | 11 | $103 | $9 |
| Amlodipine Besylate | 12 | $47 | $4 |
2013: 7 drugs
| Evista | 23 | $8,256 | $359 |
| Estrace | 23 | $3,271 | $142 |
| Premarin | 22 | $3,111 | $141 |
| Prempro | 12 | $1,165 | $97 |
| Simvastatin | 27 | $222 | $8 |
| Estradiol | 12 | $168 | $14 |
| Zolpidem | 13 | $90 | $7 |
Money from drug and device companies
$98 in 2025
| 2025 | 4 | 5 | None | $98 |
| 2023 | 2 | 2 | None | $47 |
| 2022 | 2 | 4 | None | $831 |
| 2021 | 2 | 2 | None | $34 |
| 2019 | 1 | 1 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biogen | Zurzuvae | $30 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $29 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $20 | 1 payment
|
| CooperSurgical | Paragard T 380a | $19 | 1 payment
|
See all 5 published payments
| Biogen | Meals · 2025-09-09 | Zurzuvae | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-16 | Breztri | $29 |
| Sumitomo Pharma America | Meals · 2025-05-20 | Gemtesa | $20 |
| CooperSurgical | Meals · 2025-05-07 | Paragard T 380a | $19 |
| Biogen | Meals · 2025-03-25 | Zurzuvae | $15 |
See earlier years (2023, 2022, 2021, 2019)
2023: $47
| Ethicon US | Ethicon | $30 | 1 payment
|
| AbbVie | Liletta | $17 | 1 payment
|
2022: $831
| Boston Scientific | Solyx Sis System | $812 | 3 payments
|
| Abbvie | Oriahnn | $19 | 1 payment
|
2021: $34
| Pfizer | Myfembree | $17 | 1 payment
|
| Exeltis USA | Slynd | $17 | 1 payment
|
2019: $143
| Amarin Pharma | Vascepa | $143 | 1 payment
|
Professional record
- NPI
- 1689616690
- Licence
- CA A664233
- Trained
- University of Minnesota Medical School, 1995
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A664230
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2495 Hospital Dr, Ste 505, Mountain View, CA, 94040
- NPI first listed
- 2006-06-12
- NPI last updated
- 2020-06-19
- NPI record certified
- 2020-06-19
This is when the NPI record was last certified, not a medical board exam.